Synovial vascular patterns and angiogenic factors expression in synovial tissue and serum of patients with rheumatoid arthritis

Rheumatology

Volumn 45, Issue 8, 2006, Pages 966-971

  Salvador, G ^a   Sanmarti R ^a   Gil Torregrosa, B ^a   Garcia Peiro A ^a   Rodriguez Cros J R ^a   Canete J D ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Angiogenesis; Arthroscopy; Rheumatoid arthritis; Synovial tissue; Vascular pattern

Indexed keywords

ANGIOGENIC FACTOR; ANTIRHEUMATIC AGENT; AZATHIOPRINE; C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HYDROXYCHLOROQUINE; INFLIXIMAB; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 8 ANTIBODY; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE; STEROID; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ANGIOGENESIS; ARTHROSCOPY; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIGITAL IMAGING; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SEROLOGY; SYNOVIUM;

ADULT; AGED; ANGIOGENESIS INDUCING AGENTS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ARTHROSCOPY; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-8; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SYNOVIAL MEMBRANE; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33747838110     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel043     Document Type: Article

References (29)

1. Tak PP. Analyzing synovial tissue samples. What can we learn about early rheumatoid arthritis, the heterogeneity of the disease, and the effects of treatment? J Rheumatol 2005;32:25-6.
2. van der Pouw Kraan TC, van Gaalen FA, Karpeskovitz PV et al. Rheumatoid arthritis is a heterogeneous disease: Evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues. Arthritis Rheum 2003;48:2132-45.
3. Kraan MC, Haringman JJ, Post WJ, Verseendaal J, Breedveld FC, Tak PP. Immunohistological analysis of synovial tissue for differential diagnosis in early arthritis. Rheumatology 1999;38:1074-80.
4. Salvador G, Sanmarti R, Garcia-Peiró A, Rodríguez-Cros JR, Muñoz-Gómez J, Cañete JD. p53 Expression in rheumatoid and psoriatic arthritis synovial tissue and association with joint damage. Ann Rheum Dis 2005;64:183-7.
5. Kruithof E, Baeten D, De Rycke RL et al. Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis. Arthritis Res Ther 2005;7:R569-80.
6. Cañete JD, Martinez SE, Farrés J et al. Differential Th1/Th2 cytokine patterns in chronic arthritis: Interferon γ is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies. Ann Rheum Dis 2000;59:263-8.
7. Reece RJ, Cañete JD, Parsons WJ, Emery P, Veale DJ. Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis. Arthritis Rheum 1999;42:1481-4.
8. Fiocco U, Cozzi L, Chieco-Bianchi F et al. Vascular changes in psoriatic knee joint synovitis. J Rheumatol 2001;28:2480-6.
9. Cañete JD, Rodriguez JR, Salvador G, Gomez-Centeno A, Muñoz-Gomez J, Sanmarti R. Diagnostic usefulness of synovial vascular morphology in chronic arthritis. A systematic survey of 100 cases. Semin Arthritis Rheum 2003;32:378-87.
10. Baeten D, Demetter P, Cuvelier C et al. Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: Influence of disease duration and activity. Ann Rheum Dis 2000;59:945-53.
11. Paleolog EM. Angiogenesis in rheumatoid arthritis. Arthritis Res 2002;4(Suppl. 3):S81-S90.
12. Taylor PC, Sivakumar B. Hypoxia and angiogenesis in rheumatoid arthritis. Curr Opin Rheumatol 2005;17:293-8.
13. Fraser A, Fearon U, Reece R, Emery P, Veale D. Matrix metalloproteinase 9, apoptosis, and vascular morphology in early arthritis. Arthritis Rheum 2001;44:2024-8.
14. Fearon U, Griosios K, Fraser A et al. Angiopoietins, growth factors, and vascular morphology in early arthritis. J Rheumatol 2003; 30:260-8.
15. Tak PP, Brenishan B. The pathogenesis and prevention of joint damage in rheumatoid arthritis. Arthritis Rheum 2000;43: 2619-33.
16. Cañete JD, Pablos JL, Sanmartí R et al. Antiangiogenic effects of anti-tumour necrosis factor α therapy with infliximab in psoriatic arthritis. Arthritis Rheum 2004;50:1636-41.
17. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
18. Holten J, Smeets TJM, Blankert P, Tak PP. Expression of interferon β (IFNβ) in synovial tissue from rheumatoid arthritis patients compared to osteoarthritis and reactive arthritis patients. Ann Rheum Dis 2005;64:1780-2.
19. Haringmann JJ, Vinkenoog M, Gerlag DM, Smeets TJM, Zwinderman AH, Tak PP. Reliability of computerized image analysis for the evaluation of serial synovial biopsies in randomised controlled trials in rheumatoid arthritis. Arthritis Res Ther 2005; 7:R862-7.
20. Wolfe F, Sharp JT. Radiographic outcome of recent-onset rheumatoid arthritis: A 19-year study of radiographic progression. Arthritis Rheum 1998;41:1571-82.
21. Klimiuk PA, Sierakowski S, Latosiewicz R et al. Histological patterns of synovitis and serum chemokines in patients with rheumatoid arthritis. J Rheumatol 2005;32:1666-71.
22. Eriksson P, Andersson C, Ekerfelt C, Ernerudh J, Skogh T. Relationship between serum levels of IL-18 and IgG1 in patients with primary Sjögren's syndrome, rheumatoid arthritis and healthy controls. Clin Exp Immunol 2004;137:617-20.
23. O'Shea JJ, Ma A, Lipsky P. Cytokines and autoimmunity. Nat Rev Immunol 2002;2:37-45.
24. Kim HY, Kim HJ, Min HS et al. NKT cells promote antibodyinduced joint inflammation by suppressing transforming growth factor β1 production. J Exp Med 2005;201:41-7.
25. Korpelaine EI, Karkkainen M, Gunji Y, Vikkula M, Alitalo K. Endothelial receptor tyrosine kinases activate the STAT signaling pathway: Mutant Tie-2 causing venous malformations signals a distinct STAT activation response. Oncogene 1999;18:1-8.
26. Mezquita J, Mezquita B, Pau M, Mezquita C. Down-regulation of Flt-1 gene expression by the proteasome inhibitor MG262. J Cell Biochem 2003;89:1138-47.
27. De Bandt M, Ben Mahdi M, Ollivier V et al. Blockade of vascular endothelial growth factor receptor I (VEGF-RI), but not VEGF-RII, suppresses joint destruction in the K/BxN model of rheumatoid arthritis. J Immunol 2003;171:4853-9.
28. Lee S, Jilani SM, Nikolova GV, Carpizo D, Iruela-Arispe ML. Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J Cell Biol 2005; 169:681-91.
29. Klagsbrun M, Eichmann A. A role for axon guidance receptors and ligands in blood vessel development and tumor angiogenesis. Cytokine Growth Factor Rev 2005;16:535-48.